NCT02752724View on ClinicalTrials.gov

Ketamine Anesthesia for Improvement of Depression in ECT

NACompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

April 30, 2017

Study Completion Date

April 30, 2018

Conditions
Major Depressive Disorder
Interventions
DRUG

Ketamine

Ketamine anesthesia for ECT index course with measurement cerebral metabolic regional oximetry, EEG seizure quality, cognitive scoring and serum metabolites.

DRUG

Methohexital

Methohexital anesthesia for ECT index course with measurement cerebral metabolic regional oximetry, EEG seizure quality, cognitive scoring and serum metabolites.

Trial Locations (1)

98108

VA Puget Sound Health Care System, Seattle

All Listed Sponsors
lead

VA Puget Sound Health Care System

FED

NCT02752724 - Ketamine Anesthesia for Improvement of Depression in ECT | Biotech Hunter | Biotech Hunter